We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
Cap. Flow
+$92.3M
Cap. Flow %
0.03%
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.37B
2
DD icon
DuPont de Nemours
DD
+$556M
3
QCOM icon
Qualcomm
QCOM
+$405M
4
MRK icon
Merck
MRK
+$333M
5
TSM icon
TSMC
TSM
+$315M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Consumer Discretionary 12.98%
3 Financials 12.81%
4 Healthcare 12.54%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAMG icon
3076
Silvercrest Asset Management
SAMG
$79.9M
$460K ﹤0.01%
31,959
-1,366
-4% -$20.1K
BMA icon
3077
Banco Macro
BMA
$5.35B
$459K ﹤0.01%
34,412
-2,400
-7% -$33.9K
EVFM
3078
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$459K ﹤0.01%
17,511
-727
-4% -$33K
AIFU
3079
AIFU Inc
AIFU
$221M
$448K ﹤0.01%
80
-4
-5% -$23.4K
KRMD icon
3080
KORU Medical Systems
KRMD
$164M
$447K ﹤0.01%
127,099
+4,789
+4% +$20.7K
NH
3081
DELISTED
NantHealth, Inc
NH
$444K ﹤0.01%
9,222
+1,125
+14% +$65.2K
PFHD
3082
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$443K ﹤0.01%
24,092
+740
+3% +$12.4K
MRKR icon
3083
Marker Therapeutics
MRKR
$18.7M
$431K ﹤0.01%
19,257
-384
-2% -$8.79K
AC
3084
DELISTED
Associated Capital Group
AC
$428K ﹤0.01%
11,929
-289
-2% -$10.3K
PVLA
3085
Palvella Therapeutics
PVLA
$2.27B
$428K ﹤0.01%
2,084
+15
+0.7% +$3.28K
INZY
3086
DELISTED
Inozyme Pharma
INZY
$422K ﹤0.01%
21,292
REV
3087
DELISTED
Revlon, Inc.
REV
$422K ﹤0.01%
34,241
-1,638
-5% -$19.1K
PCB icon
3088
PCB Bancorp
PCB
$391M
$421K ﹤0.01%
28,055
VYGR icon
3089
Voyager Therapeutics
VYGR
$201M
$421K ﹤0.01%
89,401
-3,681
-4% -$25.1K
EXTN
3090
DELISTED
Exterran Corporation
EXTN
$420K ﹤0.01%
124,888
-23,423
-16% -$109K
ASUR icon
3091
Asure Software
ASUR
$250M
$411K ﹤0.01%
53,768
+10,414
+24% +$83.4K
CFRX
3092
DELISTED
ContraFect Corporation
CFRX
$403K ﹤0.01%
1,051
-361
-26% -$156K
SREV
3093
DELISTED
ServiceSource International, Inc.
SREV
$399K ﹤0.01%
271,905
-19,075
-7% -$31.5K
MBII
3094
DELISTED
Marrone Bio Innovations, Inc.
MBII
$391K ﹤0.01%
186,955
-7,013
-4% -$14.6K
CMCT
3095
Creative Media & Community Trust
CMCT
$13M
$387K ﹤0.01%
1
GALT icon
3096
Galectin Therapeutics
GALT
$348M
$384K ﹤0.01%
177,035
-7,816
-4% -$17.5K
MPB icon
3097
Mid Penn Bancorp
MPB
$952M
$383K ﹤0.01%
14,300
CCB icon
3098
Coastal Financial
CCB
$693M
$377K ﹤0.01%
14,377
FUNC icon
3099
First United
FUNC
$289M
$377K ﹤0.01%
21,410
-846
-4% -$14.8K
MLP icon
3100
Maui Land & Pineapple Co
MLP
$344M
$377K ﹤0.01%
32,620
-1,539
-5% -$18.1K

Similar funds

Nuveen's Q1 2021 Portfolio in Review

As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
  • Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
  • Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
  • Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
  • Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
  • Nuveen opened 118 new positions and closed 82 in Q1 2021.
  • Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.